TOI
NASDAQ · Health Care
Oncology Institute Inc/The
$5.28
-0.23 (-4.17%)
Financial Highlights (FY 2026)
Revenue
524.19M
Net Income
-63,195,053
Gross Margin
15.2%
Profit Margin
-12.1%
Rev Growth
+25.8%
D/E Ratio
25.95
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 15.2% | 15.2% | 54.9% | 54.9% |
| Operating Margin | -7.2% | -6.5% | 16.6% | 15.3% |
| Profit Margin | -12.1% | -11.5% | 14.5% | 15.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 524.19M | 416.69M | 77.47M | 69.37M |
| Gross Profit | 79.68M | 63.34M | 42.55M | 38.11M |
| Operating Income | -37,636,943 | -26,926,270 | 12.86M | 10.62M |
| Net Income | -63,195,053 | -45,211,087 | 11.21M | 10.99M |
| Gross Margin | 15.2% | 15.2% | 54.9% | 54.9% |
| Operating Margin | -7.2% | -6.5% | 16.6% | 15.3% |
| Profit Margin | -12.1% | -11.5% | 14.5% | 15.8% |
| Rev Growth | +25.8% | +25.8% | +0.6% | -2.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 254.16M | 254.16M | 66.92M | 74.82M |
| Total Equity | 9.79M | 9.79M | 141.02M | 147.52M |
| D/E Ratio | 25.95 | 25.95 | 0.47 | 0.51 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -30,383,719 | -22,944,779 | 16.24M | 13.18M |
| Free Cash Flow | — | — | 11.97M | 11.86M |